{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T04:19:59Z","timestamp":1744777199208,"version":"3.40.4"},"reference-count":33,"publisher":"Walter de Gruyter GmbH","issue":"3","license":[{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Health Commission of Guangxi Zhuang Autonomous Region","award":["Z-K20241742"],"award-info":[{"award-number":["Z-K20241742"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec id=\"j_jpm-2024-0449_abs_001\">\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>This study aims to assess the value of copy number variation sequencing (CNV-seq) in prenatal diagnosis of abnormal ultrasound markers to reduce fetal birth defects.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpm-2024-0449_abs_002\">\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Between June 2021 and December 2022, Yulin Maternal and Child Health Care Hospital examined 295 pregnant women with abnormal ultrasound indicators. We were categorized by the number of abnormalities and age. Karyotype analysis and CNV-seq were conducted, and the CNV-seq detection rate was statistically analyzed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpm-2024-0449_abs_003\">\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>CNV-seq detected abnormal chromosomes in 43 out of 295 pregnant women with abnormal fetal ultrasound soft indicators, resulting in a detection rate of 14.58\u202f%, compared to 5.76\u202f% with traditional karyotype analysis. CNV-seq identified all aneuploidy abnormalities found by karyotype analysis and an additional 5 abnormalities, increasing the detection rate by 1.69\u202f%. However, CNV-seq missed one case of chromosome equilibrium translocation. The detection rate of CNV-seq in fetuses with Several abnormal soft indexes was 29.41\u202f%, significantly higher than individual soft indexes (p&lt;0.05). The study compared abnormality rates of single and multiple ultrasound soft markers in two age groups. Abnormal detection rates were 12.38\u202f% for the younger group and 13.73\u202f% for the older group, with no significant difference. However, the younger group had a significantly higher detection rate for multiple soft markers compared to the older group (\u03c7<jats:sup>2<\/jats:sup>=5.517, p&lt;0.05).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpm-2024-0449_abs_004\">\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>CNV-seq technology is valuable for identifying fetuses with abnormal soft markers, guiding its future use in perinatal diagnosis and aiding clinical genetic counseling.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1515\/jpm-2024-0449","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:35:55Z","timestamp":1740126955000},"page":"338-349","source":"Crossref","is-referenced-by-count":0,"title":["Copy number variation sequencing detection technology for identifying fetuses with abnormal soft indicators: a comprehensive study"],"prefix":"10.1515","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0944-6696","authenticated-orcid":false,"given":"Guangting","family":"Lu","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory , 660603 Yulin Maternal and Child Health Care Hospital , Yulin City , Guangxi , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwu","family":"Liu","sequence":"additional","affiliation":[{"name":"Obstetrical Department , 660603 Yulin Maternal and Child Health Care Hospital , Yulin City , Guangxi , China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2025,2,24]]},"reference":[{"key":"2025041510091105271_j_jpm-2024-0449_ref_001","doi-asserted-by":"crossref","unstructured":"Shaw, SWS, Chen, C-P, Cheng, P-J. From down syndrome screening to noninvasive prenatal testing: 20 years\u2019 experience in Taiwan. Taiwan J Obstet Gynecol 2013;52:470\u20134. https:\/\/doi.org\/10.1016\/j.tjog.2013.10.003.","DOI":"10.1016\/j.tjog.2013.10.003"},{"key":"2025041510091105271_j_jpm-2024-0449_ref_002","doi-asserted-by":"crossref","unstructured":"Choi, H, Lau, TK, Jiang, FM, Chan, MK, Zhang, HY, Lo, PSS, et al.. Fetal aneuploidy screening by maternal plasma DNA sequencing: \u2018False positive\u2019 due to confined placental mosaicism. Prenat Diagn 2012;33:198\u2013200. https:\/\/doi.org\/10.1002\/pd.4024.","DOI":"10.1002\/pd.4024"},{"key":"2025041510091105271_j_jpm-2024-0449_ref_003","unstructured":"Torella, M, Tormettino, B, Zurzolo, V, Labriola, D, Ambrosio, D, Stradella, L, et al.. Screening for trisomy 21 by maternal age fetal nuchal translucency thickness and maternal serum sample. Minerva Ginecol 2013;65:653\u20139."},{"key":"2025041510091105271_j_jpm-2024-0449_ref_004","doi-asserted-by":"crossref","unstructured":"Brumfield, CG, Wenstrom, KD, Owen, J, Davis, RO. Ultrasound findings and multiple marker screening in trisomy 18. Obstet Gynecol 2000;95:51\u20134. https:\/\/doi.org\/10.1097\/00006250-200001000-00011.","DOI":"10.1097\/00006250-200001000-00011"},{"key":"2025041510091105271_j_jpm-2024-0449_ref_006","doi-asserted-by":"crossref","unstructured":"Wang, J-C, Ross, L, Mahon, LW, Owen, R, Hemmat, M, Wang, BT, et al.. Regions of homozygosity identified by oligonucleotide SNP arrays: evaluating the incidence and clinical utility. Eur J Hum Genet 2015;23:663\u201371. https:\/\/doi.org\/10.1038\/ejhg.2014.153.","DOI":"10.1038\/ejhg.2014.153"},{"key":"2025041510091105271_j_jpm-2024-0449_ref_007","doi-asserted-by":"crossref","unstructured":"Hurd, PJ, Nelson, CJ. Advantages of next-generation sequencing versus the microarray in epigenetic research. Briefings Funct Genom Proteom 2009;8:174\u201383. https:\/\/doi.org\/10.1093\/bfgp\/elp013.","DOI":"10.1093\/bfgp\/elp013"},{"key":"2025041510091105271_j_jpm-2024-0449_ref_005","unstructured":"Clinical Genetics Group of Medical Genetics Branch Chinese Medical Association, Professional Committee for Prenatal Diagnosis of Genetic Diseases Medical Genetics Branch of Chinese Medical Association, Group of Genetic Disease Prevention, Control Birth Defect Prevention, Control Committee of Chinese Society of Preventive Medicine. Expert consensus on the application of low-depth whole genome sequencing in prenatal diagnosis. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2019;36:293\u20136."},{"key":"2025041510091105271_j_jpm-2024-0449_ref_008","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Acero, M, Su\u00e1rez-Obando, F, G\u00f3mez-Guti\u00e9rrez, A. CGH analysis in Colombian patients: findings of 1374 arrays in a seven-year study. Mol Cytogenet 2018;11:1\u20137. https:\/\/doi.org\/10.1186\/s13039-018-0398-9.","DOI":"10.1186\/s13039-018-0398-9"},{"key":"2025041510091105271_j_jpm-2024-0449_ref_009","doi-asserted-by":"crossref","unstructured":"Wang, J, Chen, L, Zhou, C, Wang, L, Xie, H, Xiao, Y, et al.. Prospective chromosome analysis of 3429 amniocentesis samples in China using copy number variation sequencing. Am J Obstet Gynecol 2018;219:287.e1\u201318. https:\/\/doi.org\/10.1016\/j.ajog.2018.05.030.","DOI":"10.1016\/j.ajog.2018.05.030"},{"key":"2025041510091105271_j_jpm-2024-0449_ref_010","doi-asserted-by":"crossref","unstructured":"Lan, L, She, L, Zhang, B, He, Y, Zheng, Z. Prenatal diagnosis of 913 fetuses samples using copy number variation sequencing. J Gene Med 2021;23:e3324. https:\/\/doi.org\/10.1002\/jgm.3324.","DOI":"10.1002\/jgm.3324"},{"key":"2025041510091105271_j_jpm-2024-0449_ref_011","doi-asserted-by":"crossref","unstructured":"Wang, J, Chen, L, Zhou, C, Wang, L, Xie, H, Xiao, Y, et al.. Identification of copy number variations among fetuses with ultrasound soft markers using next-generation sequencing. Sci Rep 2018;8:8134. https:\/\/doi.org\/10.1038\/s41598-018-26555-6.","DOI":"10.1038\/s41598-018-26555-6"},{"key":"2025041510091105271_j_jpm-2024-0449_ref_012","doi-asserted-by":"crossref","unstructured":"Roozbeh, N, Azizi, M, Darvish, L. Pregnancy outcome of abnormal nuchal translucency: a systematic review. J Clin Diagn Res 2017;11:QC12\u20136. https:\/\/doi.org\/10.7860\/JCDR\/2017\/23755.9384.","DOI":"10.7860\/JCDR\/2017\/23755.9384"},{"key":"2025041510091105271_j_jpm-2024-0449_ref_013","doi-asserted-by":"crossref","unstructured":"Souka, AP, von Kaisenberg, CS, Hyett, JA, Sonek, JD, Nicolaides, KH. Increased nuchal translucency with normal karyotype. Am J Obstet Gynecol 2005;192:1005\u201321. https:\/\/doi.org\/10.1016\/j.ajog.2004.12.093.","DOI":"10.1016\/j.ajog.2004.12.093"},{"key":"2025041510091105271_j_jpm-2024-0449_ref_014","doi-asserted-by":"crossref","unstructured":"Shakoor, S, Dileep, D, Tirmizi, S, Rashid, S, Amin, Y, Munim, S. Increased nuchal translucency and adverse pregnancy outcomes. J Matern Fetal Neonatal Med 2016;30:1760\u20133. https:\/\/doi.org\/10.1080\/14767058.2016.1224836.","DOI":"10.1080\/14767058.2016.1224836"},{"key":"2025041510091105271_j_jpm-2024-0449_ref_015","doi-asserted-by":"crossref","unstructured":"Leung, TY, Vogel, I, Lau, TK, Chong, W, Hyett, JA, Petersen, OB, et al.. Identification of submicroscopic chromosomal aberrations in fetuses with increased nuchal translucency and apparently normal karyotype. Ultrasound Obstet Gynecol 2011;38:314\u20139. https:\/\/doi.org\/10.1002\/uog.8988.","DOI":"10.1002\/uog.8988"},{"key":"2025041510091105271_j_jpm-2024-0449_ref_016","doi-asserted-by":"crossref","unstructured":"Scala, C, Familiari, A, Pinas, A, Papageorghiou, AT, Bhide, A, Thilaganathan, B, et al.. Perinatal and long\u2010term outcomes in fetuses diagnosed with isolated unilateral ventriculomegaly: systematic review and meta\u2010analysis. Ultrasound Obstet Gynecol 2017;49:450\u20139. https:\/\/doi.org\/10.1002\/uog.15943.","DOI":"10.1002\/uog.15943"},{"key":"2025041510091105271_j_jpm-2024-0449_ref_017","doi-asserted-by":"crossref","unstructured":"Pagani, G, Thilaganathan, B, Prefumo, F. Neurodevelopmental outcome in isolated mild fetal ventriculomegaly: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2014;44:254\u201360. https:\/\/doi.org\/10.1002\/uog.13364.","DOI":"10.1002\/uog.13364"},{"key":"2025041510091105271_j_jpm-2024-0449_ref_018","doi-asserted-by":"crossref","unstructured":"Sethna, F, Tennant, PWG, Rankin, J, Robson, SC. Prevalence, natural history, and clinical outcome of mild to moderate ventriculomegaly. Obstet Gynecol 2011;117:867\u201376. https:\/\/doi.org\/10.1097\/aog.0b013e3182117471.","DOI":"10.1097\/AOG.0b013e3182117471"},{"key":"2025041510091105271_j_jpm-2024-0449_ref_019","doi-asserted-by":"crossref","unstructured":"Cicero, S, Longo, D, Rembouskos, G, Sacchini, C, Nicolaides, KH. Absent nasal bone at 11\u201314\u00a0weeks of gestation and chromosomal defects. Ultrasound Obstet Gynecol 2003;22:31\u20135. https:\/\/doi.org\/10.1002\/uog.170.","DOI":"10.1002\/uog.170"},{"key":"2025041510091105271_j_jpm-2024-0449_ref_020","doi-asserted-by":"crossref","unstructured":"Findley, R, Allen, VM, Brock, J-AK. Adverse perinatal conditions associated with prenatally detected fetal echogenic bowel in Nova Scotia. J Obstet Gynaecol Can 2018;40:555\u201360. https:\/\/doi.org\/10.1016\/j.jogc.2017.09.017.","DOI":"10.1016\/j.jogc.2017.09.017"},{"key":"2025041510091105271_j_jpm-2024-0449_ref_021","unstructured":"De Oronzo, MA. Hyperechogenic fetal bowel: an ultrasonographic marker for adverse fetal and neonatal outcome? J Prenat Med 2011;5:9\u201313."},{"key":"2025041510091105271_j_jpm-2024-0449_ref_022","doi-asserted-by":"crossref","unstructured":"Ronin, C, Mace, P, Stenard, F, Loundou, A, Capelle, M, Mortier, I, et al.. Antenatal prognostic factor of fetal echogenic bowel. Eur J Obstet Gynecol Reprod Biol 2017;212:166\u201370. https:\/\/doi.org\/10.1016\/j.ejogrb.2017.01.060.","DOI":"10.1016\/j.ejogrb.2017.01.060"},{"key":"2025041510091105271_j_jpm-2024-0449_ref_023","doi-asserted-by":"crossref","unstructured":"Sullivan, A, Giudice, T, Vavelidis, F, Thiagarajah, S. Choroid plexus cysts: is biochemical testing a valuable adjunct to targeted ultrasonography? Am J Obstet Gynecol 1999;181:260\u20135. https:\/\/doi.org\/10.1016\/s0002-9378(99)70545-4.","DOI":"10.1016\/S0002-9378(99)70545-4"},{"key":"2025041510091105271_j_jpm-2024-0449_ref_024","doi-asserted-by":"crossref","unstructured":"Kupferminc, MJ, Tamura, RK, Sabbagha, RE, Parilla, BV, Cohen, LS, Pergament, E. Isolated choroid plexus cyst(s): an indication for amniocentesis. Am J Obstet Gynecol 1994;171:1068\u201371. https:\/\/doi.org\/10.1016\/0002-9378(94)90037-x.","DOI":"10.1016\/0002-9378(94)90037-X"},{"key":"2025041510091105271_j_jpm-2024-0449_ref_025","doi-asserted-by":"crossref","unstructured":"Cheng, P-J, Shaw, S-W, Soong, Y-K. Association of fetal choroid plexus cysts with trisomy 18 in a population previously screened by nuchal translucency thickness measurement. J Soc Gynecol Investig 2006;13:280\u20134. https:\/\/doi.org\/10.1016\/j.jsgi.2006.02.013.","DOI":"10.1016\/j.jsgi.2006.02.013"},{"key":"2025041510091105271_j_jpm-2024-0449_ref_026","doi-asserted-by":"crossref","unstructured":"Lu, J-W, Lin, L, Xiao, L-P, Li, P, Shen, Y, Zhang, X-L, et al.. Prognosis of 591 fetuses with ultrasonic soft markers during mid-term pregnancy. Curr Med Sci 2017;37:948\u201355. https:\/\/doi.org\/10.1007\/s11596-017-1833-6.","DOI":"10.1007\/s11596-017-1833-6"},{"key":"2025041510091105271_j_jpm-2024-0449_ref_027","doi-asserted-by":"crossref","unstructured":"Markus\u2010Bustani, K, Yaron, Y, Goldstein, M, Orr\u2010Urtreger, A, Ben\u2010Shachar, S. Undetected sex chromosome aneuploidy by chromosomal microarray. Prenat Diagn 2012;32:1117\u20138. https:\/\/doi.org\/10.1002\/pd.3979.","DOI":"10.1002\/pd.3979"},{"key":"2025041510091105271_j_jpm-2024-0449_ref_028","doi-asserted-by":"crossref","unstructured":"Wang, H, Chau, MHK, Cao, Y, Kwok, KY, Choy, KW. Chromosome copy number variants in fetuses with syndromic malformations. Birth Defects Res 2017;109:725\u201333. https:\/\/doi.org\/10.1002\/bdr2.1054.","DOI":"10.1002\/bdr2.1054"},{"key":"2025041510091105271_j_jpm-2024-0449_ref_029","doi-asserted-by":"crossref","unstructured":"Wou, K, Levy, B, Wapner, RJ. Chromosomal microarrays for the prenatal detection of microdeletions and microduplications. Clin Lab Med 2016;36:261\u201376. https:\/\/doi.org\/10.1016\/j.cll.2016.01.017.","DOI":"10.1016\/j.cll.2016.01.017"},{"key":"2025041510091105271_j_jpm-2024-0449_ref_030","doi-asserted-by":"crossref","unstructured":"Wilch, ES, Morton, CC. Historical and clinical perspectives on chromosomal translocations. In: Zhang, Y, editor. Advances in experimental medicine and biology. Singapore: Springer; 2018:1\u201314 pp.","DOI":"10.1007\/978-981-13-0593-1_1"},{"key":"2025041510091105271_j_jpm-2024-0449_ref_031","doi-asserted-by":"crossref","unstructured":"Kaser, D. The status of genetic screening in recurrent pregnancy loss. Obstet Gynecol Clin N Am 2018;45:143\u201354. https:\/\/doi.org\/10.1016\/j.ogc.2017.10.007.","DOI":"10.1016\/j.ogc.2017.10.007"},{"key":"2025041510091105271_j_jpm-2024-0449_ref_032","doi-asserted-by":"crossref","unstructured":"Zhang, X, Chen, L, Wang, X, Wang, X, Jia, M, Ni, S, et al.. Changes in maternal age and prevalence of congenital anomalies during the enactment of China\u2019s universal two-child policy (2013-2017) in Zhejiang Province, China: an observational study. PLoS Med 2020;17:e1003047. https:\/\/doi.org\/10.1371\/journal.pmed.1003047.","DOI":"10.1371\/journal.pmed.1003047"},{"key":"2025041510091105271_j_jpm-2024-0449_ref_033","doi-asserted-by":"crossref","unstructured":"Hu, Z-M, Li, L-L, Zhang, H, Zhang, H-G, Liu, R-Z, Yu, Y. Clinical application of chromosomal microarray analysis in pregnant women with advanced maternal age and fetuses with ultrasonographic soft markers. Med Sci Monit 2021;27:e929074. https:\/\/doi.org\/10.12659\/msm.929074.","DOI":"10.12659\/MSM.929074"}],"container-title":["Journal of Perinatal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpm-2024-0449\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpm-2024-0449\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T10:11:02Z","timestamp":1744711862000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpm-2024-0449\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,24]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,12,25]]},"published-print":{"date-parts":[[2025,3,26]]}},"alternative-id":["10.1515\/jpm-2024-0449"],"URL":"https:\/\/doi.org\/10.1515\/jpm-2024-0449","relation":{},"ISSN":["0300-5577","1619-3997"],"issn-type":[{"type":"print","value":"0300-5577"},{"type":"electronic","value":"1619-3997"}],"subject":[],"published":{"date-parts":[[2025,2,24]]}}}